Legal Issues around 3D Printed Drugs – Presented by An Vijverman, Dewallens & Partners Law Firm at The 3D Medicine & Pharmaceutical Printing Conference which will take place on Feb 01, 2017 at MECC Maastricht in The Netherlands.
In this presentation it will be analyzed whether and how 3D printed Drugs could fit within the actual legal framework concerning medicinal products: can the 3D printed drug qualify as an industrially prepared medicinal product; or as a magistral or officinal formula; or as an ATMP; or as a bona fida unsolicited order; or …? And what about the applicable GMP requirements? What are possible liability issues and how will 3D drug printing comply with the applicable data protection legislation?
About An Vijverman
An Vijverman is a lawyer specialized in health law. Her niche within health law is data protection, eHealth, pharmaceutical and medical devices law, medical aps and life sciences.
About Dewallens & partners law firm
Dewallens & partners is the leading Belgium law firm specialized in health law and life sciences. We are the Belgian member of the Alliance of European Life Sciences Law Firms. Dewallens & partners is also the highest ranked niche healthcare and life sciences law firm in Belgium in the Legal 500 of 2016.